Invesco
XFOR icon

Invesco’s X4 Pharmaceuticals XFOR Stock Holding History

Invesco’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.5K Buy
+19,968
New +$74.8K ﹤0.01% 3648
2025
Q2 		– Sell
-1,940
Closed -$13.8K – 3891
2025
Q1 		$13.8K Sell
1,940
-129
-6% -$1.78K ﹤0.01% 3754
2024
Q4 		$45.5K Sell
2,069
-2,057
-50% -$32.8K ﹤0.01% 3698
2024
Q3 		$82.8K Buy
4,126
+840
+26% +$17.5K ﹤0.01% 3644
2024
Q2 		$57.2K Sell
3,286
-1
-0% -$33 ﹤0.01% 3808
2024
Q1 		$137K Buy
3,287
+73
+2% +$2.03K ﹤0.01% 3713
2023
Q4 		$80.9K Buy
3,214
+513
+19% +$12.5K ﹤0.01% 3709
2023
Q3 		$88.3K Buy
2,701
+316
+13% +$13.8K ﹤0.01% 3734
2023
Q2 		$139K Buy
2,385
+1,387
+139% +$71.3K ﹤0.01% 3678
2023
Q1 		$26.1K Buy
998
+478
+92% +$14K ﹤0.01% 3799
2022
Q4 		$15.5K Buy
+520
New +$24.6K ﹤0.01% 3989

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return